ALCAM/CD166, Human (HEK293, Fc)

Applications:	COVID-19-immunoregulation
MW:	110-125 kDa
Formula:	₂₁₄(Gene_ID)Q₁₃₇₄₀ (W₂₈-A₅₂₆)(Accession)
SMILES:	WYTVNSAYGD TIIIPCRLDV PQNLMFGKWK YEKPDGSPVF IAFRSSTKKS VQYDDVPEYK DRLNLSENYT LSISNARISD EKRFVCMLVT EDNVFEAPTI VKVFKQPSKP EIVSKALFLE TEQLKKLGDC ISEDSYPDGN ITWYRNGKVL HPLEGAVVII FKKEMDPVTQ LYTMTSTLEY KTTKADIQMP FTCSVTYYGP SGQKTIHSEQ AVFDIYYPTE QVTIQVLPPK NAIKEGDNIT LKCLGNGNPP PEEFLFYLPG QPEGIRSSNT YTLTDVRRNA TGDYKCSLID KKSMIASTAI TVHYLDLSLN PSGEVTRQIG DALPVSCTIS ASRNATVVWM KDNIRLRSSP SFSSLHYQDA GNYVCETALQ EVEGLKKRES LTLIVEGKPQ IKMTKKTDPS GLSKTIICHV EGFPKPAIQW TITGSGSVIN QTEESPYING RYYSKIIISP EENVTLTCTA ENQLERTVNS LNVSAISIPE HDEADEISDE NREKVNDQA
Purity:	95.0
Description:	ALCAM/CD166 Protein, Human (HEK293, Fc), a recombinant human CD166 produced in HEK293 cells, has an Fc fragment at the C-terminus. CD166, also known as activated leukocyte cell adhesion molecule (ALCAM), is expressed by various cells in several tissues including cancer[1].
Shipping Conditions:	Ship on cold packs
Usage:	Research Use Only